The value of a brain biopsy in diagnosis and management of suspected herpes simplex encephalitis was studied in 29 patients (16 prospectively and 13 retrospectively). The biopsy showed herpes simplex encephalitis in eight, culture-negative encephalitis in 14, and was normal in three patients. It provided an alternative diagnosis in four patients, for two of whom curative treatment was available. The biopsy was complicated by a fatal intracranial haemorrhage in one patient. The low yield of alternative diagnoses suggests that a brain biopsy is not justified in the routine investigation of focal encephalitis.
The hallmarks of h (HSE) are its sever involvement, ' drugs had significant side effects.' Acyclovir is not only a more effective treatment of HSE but is also relatively free of toxicity.9 Hence, apart from the cost of therapy the duration of treatment is no longer an important issue in determining if a biopsy helps in the management of HSE.
The aim of this study was to obtain more information about the place of biopsy in the diagnosis of acute focal encephalitis and to determine how the biopsy influenced management. Results of a prospective investigation of a more consistent approach to biopsy were compared with results for patients who had presented with focal encephalitis during the preceding four years. 4 8 scan before the biopsy; both of those had 15 13 definite HSE on biopsy. 15 11 The biopsy was obtained by burr hole or 6 8 craniectomy at a site based on the location of 11 12 the focal abnormality on examination, CT scan, or EEG. Results A higher number of patients with focal encephalitis presented each year during the prospective study than in the retrospective study (table 2) . This was presumably due to a fluctuation in incidence, as the proportion of patients referred to the Neurology Department did not change. There was little difference in the proportion of patients who had a brain biopsy in the prospective and retrospective groups. The most common reasons for not obtaining a biopsy were improvement in the first 24 hours and the belief that the results of the biopsy would not alter management.
Culture of HSV from the biopsy confirmed a diagnosis of HSE in only eight of the 29 patients (28%) (table 3). All eight positive biopsies showed acute encephalitis, four with intranuclear inclusion bodies. In another 14 patients the biopsy showed acute encephalitis (two with inclusion bodies), but HSV was not cultured. There was no significant difference between the prospective and retrospective groups.
In four patients the biopsy provided an alternative diagnosis: subdural empyema, astrocytoma, acute cerebral ischaemia and a non-granulomatous lymphocytic meningitis which improved with anti-tuberculous therapy. Features that are unusual for HSE were present in three of these patients. Two patients (meningitis, subdural empyema) had symptoms for four to five weeks. The CT scan in the patient with a subdural empyema was done in 1981 and showed an area of low density in one temporal lobe but the subdural empyema was not visible. A modern CT scan- 
Discussion
Although the object of the prospective study was to adopt a more consistent approach to brain biopsy in patients with suspected HSE, the study had no obvious effect on the rates of '4 In this study, we believe that brain biopsy was only marginally helpful in the management of patients with suspected HSE and it was associated with significant morbidity. Although the small number of patients means that our conelusions must be tentative, we believe that the yield of alternative diagnoses is insufficient to justify a brain biopsy as a routine investigation in focal encephalitis. If the clinical, CSF, EEG and CT findings suggest HSE, it is reasonable to treat the patient with acyclovir without confirmation of the diagnosis by biopsy. CSF examination and CT should detect most of the treatable disorders that have been confused with HSE. Magnetic resonance imaging shows changes that are characteristic but not pathognomonic of HSE'5 and will also be helpful in excluding other lesions. Measurement of HSV antibody titres in serial CSF specimens can provide retrospective confirmation of the diagnosis of HSE in many patients,3 while detection of HSV antigens or DNA in CSF may be rapid, sensitive and specific methods of diagnosing HSE in the future.6 17 A brain biopsy should be considered for patients in whom the presenting features are not characteristic of HSE or if progress during treatment with acyclovir is not satisfactory.
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